All In MedTech

Device Trial Radar · NCT07276685

Evaluation of the Success of TheraCal PT in Pulpotomy Treatment of Primary Teeth Using Low-Level Laser Therapy

Evaluation of the Success of TheraCal PT and Biodentine in Pulpotomy Treatment of Primary Teeth and the Effect of Low-Level Laser Therapy (LLLT) on Treatment Outcomes

Last checked: Nov 19, 2026Latest source record: Dec 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Jan 5, 2023

Primary completion

Jul 5, 2025

Study completion Oct 15, 2025

Sponsor

Lead sponsor
NECIBE DAMLA ŞAHINAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Tokat Gaziosmanpasa University
First posted
Dec 11, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 6 years, up to 9 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This randomized clinical study aimed to compare the clinical and radiographic outcomes of TheraCal PT and Biodentine in pulpotomy treatment of primary teeth and to evaluate the influence of low-level laser therapy (LLLT) on treatment outcomes in pediatric patients.

Conditions

  • Primary Tooth Pulpotomy
  • Vital Pulp Therapy

Interventions

  • Biodentine PulpotomyProcedure

    After coronal pulp removal, Biodentine (Septodont, France) was placed over the remaining pulp tissue. No laser application was performed.

  • Low-Level Laser Therapy + BiodentineDevice

    After pulpotomy, diode laser (940 nm, 10 s, non-contact mode) was applied over the pulp chamber floor, followed by placement of Biodentine (Septodont, France).

  • TheraCal PT PulpotomyProcedure

    After coronal pulp removal, TheraCal PT (Bisco Inc., USA) was applied directly onto the pulp tissue. No laser application was performed.

  • Low-Level Laser Therapy + TheraCal PTDevice

    Following pulpotomy, a 940 nm diode laser (Biolase, USA) was applied for 10 seconds in non-contact mode, followed by application of TheraCal PT (Bisco Inc., USA).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical and Radiographic Success Rate of Pulpotomy Treatments in Primary MolarsTime frame: 12 months after treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tokat Gaziosmanpasa University Faculty of Dentistry

    Tokat Province, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.